Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124839042 | 12483904 | 2 | F | 201603 | 20160705 | 20160621 | 20160718 | EXP | JP-BAUSCH-BL-2016-014150 | BAUSCH AND LOMB | 97.00 | YR | F | Y | 0.00000 | 20160718 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124839042 | 12483904 | 1 | PS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 21119 | INJECTION | |||||||||
| 124839042 | 12483904 | 2 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 21119 | INJECTION | |||||||||
| 124839042 | 12483904 | 3 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 21119 | INJECTION | |||||||||
| 124839042 | 12483904 | 4 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 21119 | INJECTION | |||||||||
| 124839042 | 12483904 | 5 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 21119 | INJECTION | |||||||||
| 124839042 | 12483904 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 7 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 8 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 9 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 10 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 11 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 12 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 | |||||||||||
| 124839042 | 12483904 | 13 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124839042 | 12483904 | 1 | Age-related macular degeneration |
| 124839042 | 12483904 | 2 | Polypoidal choroidal vasculopathy |
| 124839042 | 12483904 | 3 | Macular degeneration |
| 124839042 | 12483904 | 6 | Age-related macular degeneration |
| 124839042 | 12483904 | 7 | Polypoidal choroidal vasculopathy |
| 124839042 | 12483904 | 8 | Macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124839042 | 12483904 | HO |
| 124839042 | 12483904 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124839042 | 12483904 | Asthenia | |
| 124839042 | 12483904 | Condition aggravated | |
| 124839042 | 12483904 | Drug effect incomplete | |
| 124839042 | 12483904 | Macular degeneration | |
| 124839042 | 12483904 | Pneumonia | |
| 124839042 | 12483904 | Polypoidal choroidal vasculopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124839042 | 12483904 | 1 | 200912 | 0 | ||
| 124839042 | 12483904 | 2 | 201003 | 0 | ||
| 124839042 | 12483904 | 3 | 201103 | 0 | ||
| 124839042 | 12483904 | 4 | 201106 | 0 | ||
| 124839042 | 12483904 | 5 | 201305 | 0 | ||
| 124839042 | 12483904 | 6 | 201008 | 0 | ||
| 124839042 | 12483904 | 7 | 201010 | 0 | ||
| 124839042 | 12483904 | 8 | 201101 | 0 | ||
| 124839042 | 12483904 | 9 | 201103 | 0 | ||
| 124839042 | 12483904 | 10 | 201106 | 0 | ||
| 124839042 | 12483904 | 11 | 201305 | 0 | ||
| 124839042 | 12483904 | 12 | 201505 | 0 | ||
| 124839042 | 12483904 | 13 | 201601 | 201601 | 0 |